Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

cancer progression prostate
Protein 4.1B suppresses prostate cancer progression and metastasis
Protein 4.1B suppresses prostate cancer progression and metastasis. Sunny Y. Wong*, {dagger} , {ddagger} , Herbert Haack*, W

Prostate Cancer: Progression, Risk Reduction, and Future Options
Eric A Klein, MD, Supplement Editor, Prostate Cancer: Progression, Risk Reduction, and Future Options. Section of Urologic Oncology, Urological Institute,

Obesity, Weight Gain, and Risk of Biochemical Failure among
Conclusions: Our findings validate the importance for a role of obesity in prostate cancer progression and suggest a link to the biological basis of

PLoS Biology - Pten Dose Dictates Cancer Progression in the Prostate
Our analysis allows a detailed deconstruction the molecular genetics underlying cancer progression in the prostate and the assessment of the key relevance

Growth factor receptor affects prostate cancer progression
Breeding mice with a gene for a cellular receptor that can be turned on and off-at will-not only enabled researchers at Baylor College of Medicine in

Lifestyle Changes May Slow Prostate Cancer Progression Prostate
Low grade prostate cancer may be slowed if men make healthful changes to their diet, physical activity level, and stress management techniques.

Integrative molecular concept modeling of prostate cancer
Here, we analyzed prostate cancer progression using an alternative resource, To identify molecular correlates of prostate cancer progression,

Growth Factor Receptor Affects Prostate Cancer Progression
"Victor started out looking for a role of fibroblast growth factor receptor 1 in prostate cancer progression and ended up with a new cancer marker and a

National Prostate Cancer Coalition: PSA Remains Best Indicator Of
PSA Remains Best Indicator Of Prostate Cancer Progression. Johns Hopkins Medical Institutions | 09.18.2005. Despite recent claims by some urologists that

Progression of Prostate Cancer - Medical Illustration
This full color medical-legal illustration shows the progression of prostate cancer with two anterior (front) cut-away views of the male genital anatomy.

Integrative molecular concept modeling of prostate cancer progression.
Using laser-capture microdissection to isolate 101 cell populations, we have profiled prostate cancer progression from benign epithelium to metastatic

Prostate Cancer Treatment (PDQ^)
25 The risk of prostate cancer progression and prostate cancer death persisted throughout the follow-up period. By the end of follow-up, 91% of the cohort

PSA REMAINS BEST INDICATOR OF PROSTATE CANCER PROGRESSION
PSA REMAINS BEST INDICATOR OF PROSTATE CANCER PROGRESSION. Despite recent claims by some urologists that measuring the blood protein prostate-specific

Growth Factor Receptor Affects Prostate Cancer Progression
Breeding mice with a gene for a cellular receptor that can be turned on and off-at will-not only enabled researchers to show how prostate cancer progresses,

Medical News: Vigorous Exercise May Slow Prostate Cancer
Vigorous Exercise May Slow Prostate Cancer Progression BOSTON, May 9-A robust exercise regimen may slow the progression of prostate cancer and reduce

eMedicine - Prostate Cancer: Metastatic and Advanced Disease
They may also limit progression of prostate cancer. They are also being studied for the treatment of osteoporosis induced by ADT.

BA - Treatment Options for Men with Advanced Prostate Cancer
BA - Treatment Options for Men with Advanced Prostate Cancer Progression Most of us with late-stage prostate cancer have few survival options except

Prostate Cancer - Natural Progression
Natural Progression. Prostate cancer tends to be a slowly progressive cancer. Absolute prediction of when a localized cancer will spread and cause

Prostate Cancer
Unlike most cancers, the rate of prostate cancer progression varies tremendously. In some men the cancer lies dormant for decades; in others it progresses


cancer progression prostate
green light prostate surgery
cancer lupron prostate radiation treatment
cancer environmental factor prostate
cancer mouse prostate virus